Ultraviolet germicidal irradiation comprises the use of ultraviolet light to kill microbes present in an enclosed area or on a specific object. It can be used on surfaces as well as for food, water, and air treatment. Ultraviolet germicidal irradiation works through the ionizing potential of ultraviolet radiation. While this is the property of ultraviolet light that can give humans skin cancer, it can also disrupt the genetic material of microbes and thus be of immense use. This is similar to the process that causes cancer, as alterations in the genetic makeup cause tumors in humans.
According to Transparency Market Research, the global ultraviolet germicidal irradiation market was worth US$168.4 mn in 2014. The increasing awareness about the importance of eliminating microbial presence is expected to propel the ultraviolet germicidal irradiation market in the coming years. The market is likely to exhibit a strong 10.9% CAGR between 2015 and 2023. Expanding at this rate, the market will reach a valuation of US$430.3 mn by 2023.
Rising Rate of Hospital-acquired Infections to Drive Demand for UV Germicidal Irradiation
Hospital-acquired infections have become a major problem for the modern global healthcare scenario. Since patients suffering from several diseases visit hospitals, a high concentration of several pathogens can be observed in hospitals. This leads to a high risk of people contracting diseases in hospitals. Ultraviolet germicidal irradiation is thus increasingly being used in hospitals to sterilize instruments and disinfect the air.
The rising demand for ultraviolet germicidal irradiation from hospitals has also been helped by the steady regulatory support for the same. Since UV germicidal irradiation makes the healthcare sector more efficient by reducing the incidence of hospital-acquired infections, many governments have expressed solid support for the technology. This is a major driver expected to benefit the global ultraviolet germicidal irradiation market in the near future.
UV Germicidal Irradiation Market Prospects Mixed in Developing Countries
Of the main geographical segments of the global ultraviolet germicidal irradiation market, North America held a dominant share in 2014. The U.S. and Canada are the leading national markets for ultraviolet germicidal irradiation, owing to the high quality of the healthcare infrastructure present in these countries. According to the Canadian Union of Public Employees, the Canadian healthcare network faces expenses of more than US$1 bn every year due to hospital-acquired infections. As a result, ultraviolet germicidal irradiation is being adopted in an increasing number of healthcare facilities as an effective first step.
On the other hand, the ultraviolet germicidal irradiation market’s prospects are mixed in developing regions such as Asia Pacific, Latin America, and Africa. While the prevalence of hospital-acquired infections is quite high in countries such as Turkey, Brazil, Tunisia, and Morocco, the healthcare sector can’t afford installing ultraviolet germicidal irradiation facilities en masse. As a result, the growth of the market is stunted in these regions. Dynamic economies such as China, India, and Brazil have stepped up their efforts to upgrade their healthcare sector, which will result in promising growth of the ultraviolet germicidal irradiation market in the coming years.
Europe is also a major market for ultraviolet germicidal irradiation due to the high technological sophistication of the healthcare sector in the region. It is expected to remain among the largest regional markets, behind North America, in the coming years.
Browse Full Global Ultraviolet Germicidal Irradiation Market Report With Complete TOC @ http://www.transparencymarketresearch.com/ultraviolet-germicidal-irradiation-market.html